NYU Langone Rheumatologists Share Insight With Online RA Community

Experts Offer Updates On Research and Treatments for Rheumatoid Arthritis with Leading Online Community Advocates

June 10, 2011 – Steven Abramson, MD, professor of medicine and director of the rheumatology division at NYU Langone Medical Center, hosted a webinar with colleagues from the medical center for rheumatoid arthritis community bloggers – bringing together, bench, bedside and the blogosphere to discuss advances in the investigation, care, and treatment of RA. The webinar can be viewed here.

“Although we have made significant advances in the treatment of RA, many people continue to have significant symptoms. Today people with RA use the Internet as a resource to stay informed and support each other – and this was a good forum to discuss advances in arthritis research here at NYU Langone with a group that not only deals with the challenges of RA – but are vocal advocates for themselves and others,” said Dr Abramson. “It’s important that information about treatments and research be shared and disseminated from appropriate and reliable sources.”

Read More: http://communications.med.nyu.edu/news/2011/…

coe_individual_logo

The Center of Excellence on Musculoskeletal Disease builds on the expertise of the NYU School of Medicine and NYU Hospital for Joint Diseases to focus on leading-edge research in arthritis, autoimmunity, and the repair and regeneration of musculoskeletal tissues.

The mission of the Center is to conduct world-class research that contributes to the understanding, treatment, cure, and prevention of musculoskeletal disease and thereby provides patients access to promising new treatments for the full spectrum of these conditions. Toward this end, we:

  • Conduct collaborative studies that examine the basic biology of joint tissues and their functional decline with age;
  • Develop methods to promote the regeneration of joint tissues;
  • Lead efforts to undersand the basic mechanisms of tissue injury in systemic lupus erythematosus and bring novel therapies to the clinic; and
  • Apply bioengineering to design more effective implants to replace defective or injured bone and cartilage.

By bringing together our most outstanding basic scientists and clinical researchers, we are able to conduct highly collaborative, multidisciplinary investigations that inspire new ideas and discoveries and that have the potential to translate scientific advances more swiftly into new ways of treating patients as well as diagnosing and preventing musculoskeletal disease.

More Info: http://coe.musculoskeletaldisease.med.nyu.edu/

1 Comment
1 comment
  1. Deb aka murphthesurf says:

    I thought the webinar was very interesting. I would liked to have seen them answer the question about how the new remission standards will impact drug trials but unfortunately it was not answered. It did have alot of good information overall and I hope to see more of this united effort in the future…bringing all the key elements together including the ra patient.

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>